Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | 0.0019 | 0.9 |
mRNA | AZD8055 | CTRPv2 | pan-cancer | AAC | -0.0023 | 0.9 |
mRNA | carboplatin:UNC0638 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0024 | 0.9 |
mRNA | AZ-3146 | CTRPv2 | pan-cancer | AAC | 0.0022 | 0.9 |
mRNA | CIL55 | CTRPv2 | pan-cancer | AAC | -0.0037 | 1 |
mRNA | QS11 | GDSC1000 | pan-cancer | AAC | -0.0022 | 1 |
mRNA | TAE684 | CCLE | pan-cancer | AAC | -0.0023 | 1 |
mRNA | BRD-K28456706 | CTRPv2 | pan-cancer | AAC | -0.0019 | 1 |
mRNA | BEC | CTRPv2 | pan-cancer | AAC | -0.0037 | 1 |
mRNA | PD-0325901 | gCSI | pan-cancer | AAC | -0.0025 | 1 |